Overview
Key Questions
Who Will Benefit from this Research?
Contents
Purchase Report
Go to PowerSteering Workspace
 
summary

This report analyzes the risk of major economic disruptions due to emerging infectious diseases, highlighted by the recent SARS epidemic. The report calls on governments and global companies to shift biosecurity strategies to focus more on addressing the root causes of these diseases. Among the findings is that SARS is the costliest in a series of infectious disease outbreaks in human and animal populations that have caused over $100 billion (not including HIV/AIDS) in damages to economies around the world over the past decade. Transcipt and audio for follow-on teleconference SARS, Biological Systems and the New Economics of Biosecurity: What are the implications for Corporate Strategies also available.